Drug Discovery - Are You Confident in Your Subvisible Particle Data?
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Free Guide: 9 Proven Flow Chemistry Teaching ExperimentsFree Guide: 9 Proven Flow Chemistry Teaching Experiments

Flow chemistry is now essential in modern synthesis training.This free 100-page guide from Vapourtec includes 9 practical experiments designed for students, educators, and researchers.

✔️ Real-world reactions
✔️ Step-by-step protocols
✔️ Ideal for academic labs and teaching programs

Download now.

Bring Flow Chemistry to Life In Your Lab
 
 
    Are You Confident in Your Subvisible Particle Data?Are You Confident in Your Subvisible Particle Data?
 
Get the full picture with your subvisible particle analysis data with FlowCam LO. Combining light obscuration (LO), and flow imaging microscopy (FIM), FlowCam LO detects particles LO alone would miss, supports regulatory compliance, and streamlines workflows. Download the white paper to learn how this dual-tech platform enhances biologics analysis.
 
Download the Whitepaper
 
 
   PhoreMost demonstrates new approach to rationalize molecular glue drug discoveryPhoreMost demonstrates new approach to rationalize molecular glue drug discovery
 
PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a study demonstrating the capabilities of its high-throughput GlueSEEKER platform to accelerate the design and development of novel molecular glue degraders.
 
 Light-activated drug discovery identifies broad-spectrum antivirals
 
Light-activated drug discovery identifies broad-spectrum antiviralsUC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT and genomics company Illumina Ventures are using optogenetics - the use of light to probe the functions of living tissue - to find compounds to help our bodies more effectively help themselves in times of physiological stress.
 
 
 Qureight analyze of Insilico Medicine's Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
 
Qureight analyze of Insilico Medicine's Phase IIa rentosertib data support preliminary efficacy results and future trial expansionQureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a collaboration with Insilico Medicine ("Insilico"), a clinical-stage biotechnology company driven by generative AI, focused on rentosertib (ISM001-055), a novel TNIK inhibitor discovered using Insilico's generative AI approach, in development for the treatment...
 
 
 Liupao tea improves metabolic syndrome risks in clinical trial
 
Liupao tea improves metabolic syndrome risks in clinical trialLiupao tea shows promise in improving metabolic syndrome markers, enhancing heart health and gut balance in just three months, according to recent research.
 
 
 Updated NeoVax cancer vaccine shows improved immune response in melanoma trial
 
Updated NeoVax cancer vaccine shows improved immune response in melanoma trialResults of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, feasible, and improves the vaccine-specific immune response compared to previous trials of the platform.
 
 
 New antibody therapy offers hope for fragile patients with Fanconi anemia
 
New antibody therapy offers hope for fragile patients with Fanconi anemiaAn antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a phase 1 clinical trial has shown.
 
 
 AI-guided patient stratification boosts Alzheimer’s trial outcomes and efficiency
 
AI-guided patient stratification boosts Alzheimer’s trial outcomes and efficiencyScientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.
 
 
 Microbial therapy uses modified bacteria to target oxalate in the gut
 
Microbial therapy uses modified bacteria to target oxalate in the gutEngineered gut bacteria designed to treat kidney stones successfully colonized the gut microbiome and reduced oxalate levels in animal models and early clinical trials in humans, researchers report.
 
 
 UAB Identifies Six Novel Subsets, Reshaping Immune Knowledge
 
UAB Identifies Six Novel Subsets, Reshaping Immune KnowledgeThe study highlights T-bet's importance in memory B cells, essential for rapid antibody production and sustained immune defense against influenza.
 
 
 Australian study uncovers first potential prophylactic treatment against HTLV-1
 
Australian study uncovers first potential prophylactic treatment against HTLV-1Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025